Pharmaceutical
Summary of Consolidated Financial Results for the Three Months Ended June 30, 2026 (IFRS)
Summary of Consolidated Financial Results for the Three Months Ended June 30, 2026 (IFRS)
About this update from Santen Pharmaceutical Co., Ltd.
Santen Pharmaceutical Co., Ltd. (4536) Press ReleaseView Attachment
View stock analysis, news, and events for Santen Pharmaceutical Co., Ltd.